logo
episode-header-image
Dec 2022
33m 37s

HIBT Lab! Immunai: Noam Solomon

Guy Raz | Wondery
About this episode
According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to develop a new drug is over $1 billion; and testing can take over 10 years. Noam Sol ... Show More
Up next
Today
Advice Line: New Offerings, Bigger Markets
Today’s callers: Kristina in Florida wants to take her local pottery workshops nationwide. Then Jim from Colorado wonders if retail is right for his quick release camera straps. And Will in Ohio hopes his business will change what consumers expect from tool rental services. Thank ... Show More
41m 47s
May 11
Room & Board: John Gabbert. A Broken Deal, a Family Rift, and the Birth of a Furniture Giant
John Gabbert built a massive furniture brand. But in order to do it, he had to defy his family. John grew up working at his dad’s furniture store in the suburbs of Minneapolis. It sold classic, American-made furniture, with flowery prints and curved legs. But in 1972, John took a ... Show More
1h 1m
May 7
Advice Line with Jonah Peretti of Buzzfeed
Today’s callers: Anthony from Miami considers the best method to grow his pop-up outdoor movie theater business. Then Andrew in San Francisco asks how to set his cat wrestling toy apart from competitors. Finally, Melissa in Massachusetts seeks strategies for getting busy parents ... Show More
43 m
Recommended Episodes
Jul 2022
Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176
What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex. Enter Immunai, a biotechnology company that’s using AI ... Show More
27m 52s
Oct 2022
A New Drug For A Relentless Brain Disease
ALS is a disease that destroys the nerve cells in the brain and spinal cord we need for voluntary movement. There is no cure, but now there is a newly approved medication that may slow down the disease and extend patients' lives. The drug, called Relyvrio, got its start with a co ... Show More
13m 3s
Nov 2022
Battling Pathogens and Building Immunity Begins In Your Gut – Dr. Robynne Chutkan : 998
<p><strong>IN THIS EPISODE OF THE HUMAN UPGRADE</strong>™…&nbsp;Robynne Chutkan, M.D., joins the show to talk about a topic that’s foundational to biohacking—resilience. More specifically, resilience that starts in the gut. You’ll learn:</p><ul><li>how your microbiome continually ... Show More
1h 17m
Mar 2023
Antibiotics: How to fix a broken market
Antibiotics stopped providing big gains for pharmaceutical companies decades ago, but as bacteria become more resistant to drugs, the world needs new classes of antibiotics to be discovered if we want to prevent the next global health crisis.Dr Tina Joshi, Associate Professor of ... Show More
18m 23s
May 2021
Lifting the burden of malaria
A new vaccine could help eliminate the disease. What would that mean for African economies?Manuela Saragosa speaks to the man who led the team behind the new vaccine, which has demonstrated a startling 77% effectiveness in recent drug trials. Adrian Hill of Oxford University's Je ... Show More
18m 29s
Jun 2023
The world of biotech: It's like you just saw somebody run one hundred meters in 2.5 seconds
You defied some of the laws of physics to make that happen!Get the dog out for a walk, hop on the train or car to work or to school, put your gym gear on and tune in to find out who’s the next guest in the Republic of Insead podcast. A few of my favorite snippets are below.20 YEA ... Show More
50m 9s
Jan 2024
JP Morgan Healthcare Conference Highlights
Weight loss drugs are taking center spotlight, but other developing treatments could change how we live. Deidre Woollard caught up with Motley Fool biotech analyst Karl Thiel to discuss: - Biogen’s next shot at an Alzheimer’s treatment. - Why companies can’t “muscle their way” i ... Show More
26m 16s
Feb 2023
Covid Brain Fog, Freemium Failure, Fungal Vaccine
Today you’ll learn about a potential new treatment for those suffering from brain fog after Covid, how freemium models of mental health apps might cause you to be more stressed out, and how developments in creating a vaccine for fungal infections might make them a thing of the pa ... Show More
19m 56s
Sep 2022
Use Your Microbiome for Better Mood, Memory, and Dreams with Dr. Jeffrey Bland
<p>What role does your microbiome take in shaping your moods, memory, and even your dreams?</p> <p>You already know that what you eat matters, especially for your brain matter. The mind-gut connection is so strong, I’ve often referred to it as your second brain. But this intercon ... Show More
20m 40s